Superparamagnetic iron oxide labeling of stem cells for MRI tracking and delivery in cardiovascular disease

Dorota Kedziorek, Dara Kraitchman

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

In the mid-1980s, iron oxide nanoparticles were developed as contrast agents for diagnostic imaging. In the last two decades, established methods to label cells with superparamagnetic iron oxides (SPIOs) have been developed to aid in targeted delivery and tracking of stem cell therapies. The surge in cellular therapy clinical trials for cardiovascular applications has seen a similar rise in the number of preclinical animal studies of SPIO-labeled stem cells in an effort to understand the mechanisms of cardiovascular regenerative therapy and stem cell biodistribution. The adoption of a limited number of methods of direct labeling of stem cells with SPIOs is due in large part to the desire to rapidly translate these techniques to clinical trials. In this review, we will outline the most commonly adopted methods for iron oxide labeling of stem cells for cardiovascular applications and describe strategies for magnetic resonance imaging (MRI) of magnetically labeled cells in the heart.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages171-183
Number of pages13
Volume660
ISBN (Print)9781607617044
DOIs
StatePublished - 2010

Publication series

NameMethods in Molecular Biology
Volume660
ISSN (Print)10643745

Fingerprint

Cardiovascular Diseases
Stem Cells
Magnetic Resonance Imaging
Clinical Trials
Diagnostic Imaging
Cell- and Tissue-Based Therapy
Nanoparticles
Contrast Media
ferric oxide
Therapeutics

Keywords

  • Cell imaging
  • Cellular labeling
  • Electroporation
  • Magnetic resonance imaging (MRI)
  • Stem cells
  • Superparamagnetic iron oxide (SPIO)
  • Transfection

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Kedziorek, D., & Kraitchman, D. (2010). Superparamagnetic iron oxide labeling of stem cells for MRI tracking and delivery in cardiovascular disease. In Methods in Molecular Biology (Vol. 660, pp. 171-183). (Methods in Molecular Biology; Vol. 660). Humana Press Inc.. https://doi.org/10.1007/978-1-60761-705-1_11

Superparamagnetic iron oxide labeling of stem cells for MRI tracking and delivery in cardiovascular disease. / Kedziorek, Dorota; Kraitchman, Dara.

Methods in Molecular Biology. Vol. 660 Humana Press Inc., 2010. p. 171-183 (Methods in Molecular Biology; Vol. 660).

Research output: Chapter in Book/Report/Conference proceedingChapter

Kedziorek, D & Kraitchman, D 2010, Superparamagnetic iron oxide labeling of stem cells for MRI tracking and delivery in cardiovascular disease. in Methods in Molecular Biology. vol. 660, Methods in Molecular Biology, vol. 660, Humana Press Inc., pp. 171-183. https://doi.org/10.1007/978-1-60761-705-1_11
Kedziorek D, Kraitchman D. Superparamagnetic iron oxide labeling of stem cells for MRI tracking and delivery in cardiovascular disease. In Methods in Molecular Biology. Vol. 660. Humana Press Inc. 2010. p. 171-183. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-60761-705-1_11
Kedziorek, Dorota ; Kraitchman, Dara. / Superparamagnetic iron oxide labeling of stem cells for MRI tracking and delivery in cardiovascular disease. Methods in Molecular Biology. Vol. 660 Humana Press Inc., 2010. pp. 171-183 (Methods in Molecular Biology).
@inbook{7c9ac684f4e547729948e23c4c1f6b26,
title = "Superparamagnetic iron oxide labeling of stem cells for MRI tracking and delivery in cardiovascular disease",
abstract = "In the mid-1980s, iron oxide nanoparticles were developed as contrast agents for diagnostic imaging. In the last two decades, established methods to label cells with superparamagnetic iron oxides (SPIOs) have been developed to aid in targeted delivery and tracking of stem cell therapies. The surge in cellular therapy clinical trials for cardiovascular applications has seen a similar rise in the number of preclinical animal studies of SPIO-labeled stem cells in an effort to understand the mechanisms of cardiovascular regenerative therapy and stem cell biodistribution. The adoption of a limited number of methods of direct labeling of stem cells with SPIOs is due in large part to the desire to rapidly translate these techniques to clinical trials. In this review, we will outline the most commonly adopted methods for iron oxide labeling of stem cells for cardiovascular applications and describe strategies for magnetic resonance imaging (MRI) of magnetically labeled cells in the heart.",
keywords = "Cell imaging, Cellular labeling, Electroporation, Magnetic resonance imaging (MRI), Stem cells, Superparamagnetic iron oxide (SPIO), Transfection",
author = "Dorota Kedziorek and Dara Kraitchman",
year = "2010",
doi = "10.1007/978-1-60761-705-1_11",
language = "English (US)",
isbn = "9781607617044",
volume = "660",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "171--183",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Superparamagnetic iron oxide labeling of stem cells for MRI tracking and delivery in cardiovascular disease

AU - Kedziorek, Dorota

AU - Kraitchman, Dara

PY - 2010

Y1 - 2010

N2 - In the mid-1980s, iron oxide nanoparticles were developed as contrast agents for diagnostic imaging. In the last two decades, established methods to label cells with superparamagnetic iron oxides (SPIOs) have been developed to aid in targeted delivery and tracking of stem cell therapies. The surge in cellular therapy clinical trials for cardiovascular applications has seen a similar rise in the number of preclinical animal studies of SPIO-labeled stem cells in an effort to understand the mechanisms of cardiovascular regenerative therapy and stem cell biodistribution. The adoption of a limited number of methods of direct labeling of stem cells with SPIOs is due in large part to the desire to rapidly translate these techniques to clinical trials. In this review, we will outline the most commonly adopted methods for iron oxide labeling of stem cells for cardiovascular applications and describe strategies for magnetic resonance imaging (MRI) of magnetically labeled cells in the heart.

AB - In the mid-1980s, iron oxide nanoparticles were developed as contrast agents for diagnostic imaging. In the last two decades, established methods to label cells with superparamagnetic iron oxides (SPIOs) have been developed to aid in targeted delivery and tracking of stem cell therapies. The surge in cellular therapy clinical trials for cardiovascular applications has seen a similar rise in the number of preclinical animal studies of SPIO-labeled stem cells in an effort to understand the mechanisms of cardiovascular regenerative therapy and stem cell biodistribution. The adoption of a limited number of methods of direct labeling of stem cells with SPIOs is due in large part to the desire to rapidly translate these techniques to clinical trials. In this review, we will outline the most commonly adopted methods for iron oxide labeling of stem cells for cardiovascular applications and describe strategies for magnetic resonance imaging (MRI) of magnetically labeled cells in the heart.

KW - Cell imaging

KW - Cellular labeling

KW - Electroporation

KW - Magnetic resonance imaging (MRI)

KW - Stem cells

KW - Superparamagnetic iron oxide (SPIO)

KW - Transfection

UR - http://www.scopus.com/inward/record.url?scp=84934441157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934441157&partnerID=8YFLogxK

U2 - 10.1007/978-1-60761-705-1_11

DO - 10.1007/978-1-60761-705-1_11

M3 - Chapter

C2 - 20680819

AN - SCOPUS:84934441157

SN - 9781607617044

VL - 660

T3 - Methods in Molecular Biology

SP - 171

EP - 183

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -